Search

… Tuesday, May 5, 2026 Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments: Christopher D. Lima Elected 2025 AAAS Fellow   Christopher D. Lima Christopher D. Lima, PhD, Chair of the Structural Biology Program at the Sloan Kettering Institute and a Howard Hughes

Learn why immuno-oncology — which seeks to rally and strengthen the immune system’s ability to fight cancer — is the world’s next frontier in cancer research, and how MSK is overcoming some of the field's biggest challenges.

… Monday, May 11, 2026 At any given moment, the human immune system is running quiet surveillance: detecting what doesn’t belong and calibrating a response strong enough to clear infection but restrained enough to avoid harming healthy cells and tissues. That discrimination is the immune system’s defining

Learn more about what the Gerstner Sloan Kettering Graduate School of Biomedical Sciences offers aspiring scientists from three distinguished alumni of the program.

… Monday, May 11, 2026 Curiosity, focus, and commitment are essential qualities for an aspiring scientist. But speak to any accomplished researcher and they will tell you strong mentorship matters most of all.  That’s why, nearly 20 years ago, the Gerstner Sloan Kettering Graduate School of Biomedical

Every year, thousands of people travel from across the country and around the world in search of hope at MSK. Learn how MSK supports patients far from home.

… Monday, May 11, 2026 Memorial Sloan Kettering Cancer Center (MSK) has always been a neighborhood hospital, focused on caring for New York City residents since welcoming its first patients in Manhattan, in 1887. Over the decades, MSK’s community has expanded to include the surrounding region, with locations

Fifteen young scientists are poised to receive their PhD degrees from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences. Their years of dedication and training will be recognized on May 13, 2026, as part of Memorial Sloan Kettering’s 47th annual academic convocation.

… Monday, May 11, 2026   On May 13, 2026, 15 new PhD scientists will officially receive their degrees from the  Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK) . The graduates will receive their diplomas as part of the 47th annual academic convocation and commencement ceremony held

A team of researchers from MSK has developed a new type of CAR T cell therapy that shows promise against acute myeloid leukemia (AML) in preclinical models.

… Tuesday, May 12, 2026 Developing effective immunotherapies for acute myeloid leukemia (AML) has long been hampered by a critical challenge: Therapy directed at killing the leukemia cells may also harm the body’s ability to make new, healthy blood cells. This happens because most of the proteins that

After a cancer diagnosis, one of the first and toughest decisions people face is how much to share in the workplace. Read more about working with cancer — and how MSK offers guidance and support.

… Monday, May 11, 2026 Any working person with cancer is forced to weigh the risks and benefits of sharing deeply personal news in the workplace, often before you can know what the diagnosis will mean. For those in leadership positions, that decision can be further complicated by a sense of responsibility

MSK doctors and scientists are leading the charge to find new and innovative ways to treat metastatic brain cancer.

… Tuesday, May 12, 2026   For patients who have been diagnosed with cancer that has spread to the brain from other parts of the body, there are more and more reasons to be hopeful. These types of tumors are increasingly being met with powerful, targeted treatments designed to eliminate them entirely, with

Learn what to do right after you've been diagnosed with brain cancer, from MSK experts who specialize in treating this kind of cancer.

… Tuesday, May 12, 2026 Being told that you or a loved one has a brain tumor is one of the scariest things you can hear.  Brain tumors may be found because someone has symptoms such as seizures, headaches, or weakness on one side of the body. Or they may be detected incidentally, because of a scan done

… Monday, May 18, 2026 In 2025, the MSK Giving community accelerated its commitment to redefine what’s possible in cancer care worldwide. Together, 348,000 donors contributed $546 million to The MSK Campaign: Leading Science. Changing Lives . The MSK Campaign is our ambitious effort to raise $6 billion